Plus: China’s Huawei says it can match cutting-edge Intel semiconductors by 2031 without equipment the U.S. has blocked it from accessing. And Eli Lilly is buying a trio of companies for around $4 billion to grow its infectious diseases business. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices